Novel therapeutic uses of alpha-1 antitrypsin: a window to the future. (Q51534901)

6 April 2018

title

Novel therapeutic uses of alpha-1 antitrypsin: a window to the future. (English)

1 reference

6 April 2018

author name string

Adam Wanner

series ordinal

1

1 reference

6 April 2018

Adriana De Arce

series ordinal

2

1 reference

6 April 2018

Erin Pardee

series ordinal

3

1 reference

6 April 2018

language of work or name

English

0 references

publication date

4 December 2012

1 reference

6 April 2018

COPD: Journal of Chronic Obstructive Pulmonary Disease

published in

1 reference

6 April 2018

volume

9

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

583-588

1 reference

6 April 2018

Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha1-antitrypsin inhibits angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Serum alpha 1-protease inhibitor in diabetes mellitus: reduced concentration and impaired activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

The discovery of α1-antitrypsin and its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Update in cystic fibrosis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.717125

10.3109/15412555.2012.717125

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

23205701

1 reference

6 April 2018